Circulating soluble Fas levels and risk of ovarian cancer
Akhmedkhanov A, Lundin E, Guller S, Lukanova A, Micheli A, Ma Y, Afanasyeva Y, Zeleniuch-Jacquotte A, Krogh V, Lenner P, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P. Circulating soluble Fas levels and risk of ovarian cancer. BMC Cancer 2003, 3: 33. PMID: 14690548, PMCID: PMC317312, DOI: 10.1186/1471-2407-3-33.Peer-Reviewed Original ResearchMeSH KeywordsBiomarkers, TumorCase-Control StudiesCohort StudiesFas ReceptorFemaleHumansMiddle AgedOvarian NeoplasmsProspective StudiesConceptsSerum sFas levelsSerum sFasOvarian cancerSFas levelsPrimary invasive epithelial ovarian cancerQuantitative sandwich enzyme immunoassayInvasive epithelial ovarian cancerSoluble Fas levelsEpithelial ovarian cancerIdentification of womenOvarian cancer riskCase-control studySandwich enzyme immunoassayMenopausal statusProspective cohortEnrollment datePotential confoundersControl subjectsSoluble FasMethodsThe associationCancer riskCase subjectsHighest thirdBlood donationPotential biomarkers